TEVA-TOPILENE
TEVA CANADA LIMITED
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of TEVA-TOPILENE in Canada?
Yes. TEVA-TOPILENE 0.05% has an active shortage reported to Health Canada (last updated June 4, 2026).
Why is TEVA-TOPILENE not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will TEVA-TOPILENE be available again?
No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
DIPROSONE
ORGANON CANADA INC.
CELESTODERM V/2 CREAM .05%
SCHERING-PLOUGH CANADA INC
TEVA-ECTOSONE
TEVA CANADA LIMITED
BETNOVATE LOT 0.1%
GLAXO CANADA INC
BETNOVATE 1/2 LOT 0.05%
GLAXO CANADA INC
BEBEN GEL 0.025%
PARKE-DAVIS DIVISION, WARNER-LAMBERT CANADA INC.
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
⚠ Possible Recall or Safety Alert
Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.
Teva-Topilene Ointment 0.05%
Teva-Topilene Ointment 0.05%: The assay is potentially out of specification in the affected lot during its shelf life.
Moderate health risk
Possible match — not confirmed
Teva-Topilene 0.05% Ointment
Teva-Topilene 0.05% Ointment: Out of Specification
Moderate health risk
Possible match — not confirmed
DIN
00849669
Strength
0.05%
Dosage Form
OINTMENT
Route
TOPICAL
Compare with another product →
Shortage Timeline
Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.
Shortage History
Disruption of the manufacture of the drug.
Disruption of the manufacture of the drug.
Other Products from TEVA CANADA LIMITED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 02143933
DIN 00834319
3.5MG · DIN 02438399
0.5MG · DIN 02301407
100MG · DIN 02420155
200MG · DIN 02420163
500MG · DIN 02247340
750MG · DIN 02247341
250MG · DIN 02247339
75MG · DIN 02303027
180MG · DIN 02370638
240MG · DIN 02370646